UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 1, 2011
BIODEL INC.
(Exact name of registrant as specified in its charter)
Commission File Number 001-33451
| Delaware (State or other jurisdiction of incorporation or organization) |
90-0136863 (IRS Employer Identification Number) |
| 100 Saw Mill Road | ||
| Danbury, Connecticut (Address of principal executive offices) |
06810 (Zip code) |
(203) 796-5000
(Registrant’s telephone number, including area code)
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Explanatory Note
This current report on Form 8-K/A updates information provided on a Form 8-K filed on March 4,
2011, relating to disclosures made under Item 5.07, Submission of Matters to a Vote of Security
Holders, associated with the Biodel Inc. (the “Company”) annual meeting of stockholders
held on March 1, 2011 (the “Annual Meeting”).
| Item 5.07 | Submission of Matters to a Vote of Security Holders |
As previously reported, at the Annual Meeting, in a non-binding advisory vote, over a majority of
the votes cast voted in favor of three years as the frequency with which the Company should hold
future non-binding advisory votes on the compensation of our named executive officers. In light of
these voting results and other factors, the Company will hold future non-binding advisory votes on
the compensation of our named executive officers on a triennial basis, until the next non-binding
advisory vote on the frequency of such votes on executive compensation.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: July 29, 2011 | BIODEL INC. |
|||
| By: | /s/ Gerard J. Michel | |||
| Gerard J. Michel, Chief Financial Officer | ||||
3